These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 13917453)

  • 21. Alpha methyl dopa in the treatment of hypertension.
    DOYLE A; TREVAKS G
    Med J Aust; 1962 Jul; 49(2)():55-6. PubMed ID: 13887654
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of adrenergic neuron inhibitors on the vascular response to sympathetic nerve stimulation.
    Kisin I
    Pharmacology; 1976; 14(4):351-6. PubMed ID: 935248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of alpha-methyl-DOPA and alpha-methyl-metatyrosine on the metabolism of norepinephrine and serotonin in vivo.
    HESS SM; CONNAMACHER RH; OZAKI M; UDENFRIEND S
    J Pharmacol Exp Ther; 1961 Nov; 134():129-38. PubMed ID: 13907002
    [No Abstract]   [Full Text] [Related]  

  • 24. [Value of alpha-methyl-dopa for the treatment of chronic hypertension].
    ARNOLD OH
    Dtsch Med Wochenschr; 1962 Apr; 87():844-8. PubMed ID: 13862447
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of alpha-methyl DOPA in severe and malignant hypertension.
    CANNON PJ; WHITLOCK RT; MORRIS RC; ANGERS M; LARAGH JH
    JAMA; 1962 Mar; 179():673-81. PubMed ID: 13876240
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of alpha-methyl-dopa on the action of tyramine in cats pretreated with reserpine].
    KRONEBERG G; STOEPEL K
    Experientia; 1963 May; 19():252-3. PubMed ID: 13927038
    [No Abstract]   [Full Text] [Related]  

  • 27. Febrile reactions to L-alpha-methyl-dopa. Report of three cases.
    LEONARD JW; GIFFORD RW; HUMPHREY DC
    Cleve Clin Q; 1962 Jul; 29():144-7. PubMed ID: 14464072
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension.
    GILLESPIE L; OATES JA; CROUT JR; SJOERDSMA A
    Circulation; 1962 Feb; 25():281-91. PubMed ID: 13898638
    [No Abstract]   [Full Text] [Related]  

  • 29. DISSOCIATION OF THE DECARBOXYLASE-INHIBITING AND NOREPINEPHRINE-DEPLETING EFFECTS OF ALPHA-METHYL-DOPA, ALPHA-ETHYL-DOPA, 4-BROMO-3-HYDROXY-BENZYLOXYAMINE AND RELATED SUBSTANCES.
    LEVINE RJ; SJOERDSMA A
    J Pharmacol Exp Ther; 1964 Oct; 146():42-7. PubMed ID: 14221224
    [No Abstract]   [Full Text] [Related]  

  • 30. 5-Hydroxytryptamine levels in brain of mice pretreated with Alpha-methyl-dopa.
    LEROY JG
    Arch Int Pharmacodyn Ther; 1961 Dec; 134():492-6. PubMed ID: 14464270
    [No Abstract]   [Full Text] [Related]  

  • 31. [alpha-Methyl-DOPA. Therapeutic experiences in hypertension and biochemical research on its mode of action].
    SCHAUB F; NAGER F; SCHAER H; ZIEGLER W; LICHTLEN P
    Schweiz Med Wochenschr; 1962 May; 92():620-8. PubMed ID: 14498080
    [No Abstract]   [Full Text] [Related]  

  • 32. [Preliminary report on the clinical effectiveness of 1-alpha-methyl-DOPA (Aldomet) in the treatment of hypertension].
    FELLINGER K; GRABNER G; KRYGICZ H
    Wien Z Inn Med; 1961 Dec; 42():527-30. PubMed ID: 13892223
    [No Abstract]   [Full Text] [Related]  

  • 33. Uptake of some catecholamines and their precursors into neurons of the rat ciliary ganglion.
    Ehinger B; Falck B
    Acta Physiol Scand; 1970 Jan; 78(1):132-41. PubMed ID: 4986830
    [No Abstract]   [Full Text] [Related]  

  • 34. EFFECTS OF RESERPINE IN RATS PRETREATED WITH ALPHA-METHYLDOPA.
    GUNNE LM; JONSSON J
    J Pharm Pharmacol; 1963 Nov; 15():774-5. PubMed ID: 14079623
    [No Abstract]   [Full Text] [Related]  

  • 35. [Influence of chronic pretreatment with alpha-methyldopa and reserpine upon the sensitivity of the vascular system to noradrenaline and hypertensin].
    Formanek K; Lindner A; Selzer H
    Med Pharmacol Exp Int J Exp Med; 1966; 15(1):45-54. PubMed ID: 4288184
    [No Abstract]   [Full Text] [Related]  

  • 36. [Trial of alpha-methyl-dopa in a case of carcinoidosis].
    GEFFROY Y; CARTIER P; LEMOINE P; FABLET J; MOREAU J; MALANDRIN C; LEGRAND M
    Pathol Biol; 1962 Jan; 10():75-7. PubMed ID: 13897491
    [No Abstract]   [Full Text] [Related]  

  • 37. AWAKENING FROM RESERPINE SEDATION BY ALPHA-METHYLDOPA.
    DAY MD; RAND MJ
    J Pharm Pharmacol; 1963 Sep; 15():631-2. PubMed ID: 14059614
    [No Abstract]   [Full Text] [Related]  

  • 38. Agranulocytosis caused by methyl dopa (Aldomet).
    HALLWRIGHT GP
    N Z Med J; 1961 Dec; 60():567-70. PubMed ID: 13903962
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of stress and drugs on the catecholamine and pepsin concentrations in stomach wall of rat.
    Grechishkin LL
    Pharmacology; 1975; 13(3):260-4. PubMed ID: 1098061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ANTAGONISM OF RESERPINE-INDUCED SUBSENSITIVITY TO TYRAMINE BY METHYLDOPA.
    VARMA DR; BENFEY BG
    J Pharmacol Exp Ther; 1963 Sep; 141():310-3. PubMed ID: 14064192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.